Agregator de ştiri

ECDC has released a new form for clinicians to help ensure patients with tuberculosis (TB) can continue their treatment without interruption when moving between countries. This form provides a standardised communication channel across the EU/EEA.

The World Health Organization (WHO) today announced its recommendations for the viral composition of influenza vaccines for use in the 2026 influenza season in the southern hemisphere. The announcement was made at an Information Meeting after a 4-day Consultation on the Composition of Influenza Virus Vaccines.

WHO Member States are actively progressing with the development of the Pathogens Access and Benefit Sharing (PABS) system, a key component of the WHO Pandemic Agreement aimed at ensuring equitable and timely sharing of pathogen materials and related benefits. This work follows the historic adoption of the WHO Pandemic Agreement and amendments to the International Health Regulations, marking significant steps toward global pandemic preparedness.

World leaders have expressed overwhelming support for the text of the first United Nations global political declaration on responding to noncommunicable diseases (NCDs) and mental health in an integrated manner. The declaration, negotiated during a five-month intergovernmental process, will be considered at the 80th session of the General Assembly for final approval in October 2025.

Rabat, 25 September 2025 - The European Centre for Disease Prevention and Control, together with Morocco’s Ministry of Health and Social Protection and the Eastern Mediterranean Public Health Network concluded a three-day training in Rabat to strengthen the country’s event-based surveillance capacities.

The World Health Organization (WHO) emphasizes that there is currently no conclusive scientific evidence confirming a possible link between autism and use of acetaminophen (also known as paracetamol) during pregnancy. 

Globally, nearly 62 million people (1 in 127) have autism spectrum disorder, a diverse group of conditions related to development of the brain. Although awareness and diagnosis have improved in recent years, the exact causes of autism have not been established, and it is understood there are multiple factors that can be involved.  

Extensive research has been undertaken over the past decade, including large-scale studies, looking into links between acetaminophen use during pregnancy and autism. At this time, no consistent association has been established. 

WHO recommends that all women continue to follow advice of their doctors or health workers, who can help assess individual circumstances and recommend necessary medicines. Any medicine should be used with caution during pregnancy, especially in the first three months, and in line with advice from health professionals. 

Also, a robust, extensive evidence base exists showing childhood vaccines do not cause autism. Large, high-quality  studies from many countries have all reached the same conclusion. Original studies suggesting a link were flawed and have been discredited. Since 1999, independent experts advising WHO have repeatedly confirmed that vaccines—including those with thiomersal or aluminum—do not cause autism or other developmental disorders.   

Childhood vaccine schedules are developed through a careful, extensive and evidence-based process involving global experts and country input. The childhood immunization schedule, carefully guided by WHO, has been adopted by all countries, and has saved at least 154 million lives over the past 50 years. The schedule remains essential for the health and wellbeing of every child and every community. These schedules have continually evolved with science and now safeguard children, adolescents and adults against 30 infectious diseases.  

Every vaccine recommendation by the Strategic Advisory Group of Experts on Immunization (SAGE), an independent advisory group to WHO, is grounded in rigorous review of evidence and carefully designed to offer the best protection against serious diseases and to be delivered when most needed.   

When immunization schedules are delayed or disrupted, or altered without evidence review, there is a sharp increase in the risk of infection not only for the child, but also for the wider community. Infants too young to be vaccinated and people with weakened immune systems or underlying health conditions are at greatest risk.  

Autism and neurodevelopmental disorders are among priority mental health and neurological conditions being discussed at the 4th UN High-Level Meeting on NCDs and mental health this Thursday, 25 September.  As a global community, we need to do more to understand the causes of autism and how best to care for and support the needs of autistic people and their families.   

WHO is committed to advancing this goal working together with partners including autistic-led organizations and other organizations representing persons with lived experience. WHO also stands with people who are living with autism and their families, a dignified community entitled to evidence-based considerations free of stigma.

The World Health Organization (WHO) today released its second Global hypertension report, showing that 1.4 billion people lived with hypertension in 2024, yet just over one in five have it under control either through medication or addressing modifiable health risks.

WHO and the European Union (EU) have renewed their collaboration on achieving universal health coverage with the launch of Phase V (2025–2028) of the Universal Health Coverage (UHC) Partnership – WHO’s largest platform for strengthening health systems and advancing primary health care.

The previously published ECDC report, 'Tools and methods for promoting vaccination acceptance and uptake: a social and behavioural science approach’ is now available in all official EU/EEA languages.

Today marks a milestone in global health governance as the amendments to the International Health Regulations (IHR) enter into force. This reflects a renewed global commitment to cooperation in the face of public health emergencies, shaped by hard-earned lessons of the COVID-19 pandemic.

The World Health Organization (WHO) today released a new report titled “Saving lives, spending less”, revealing that an additional investment of just US$3 per person annually in tackling noncommunicable diseases (NCDs) could yield economic benefits of up to US$1 trillion by 2030.

Every month ECDC provides detailed epidemiological overview of the worldwide transmission of dengue in its weekly threat report (Communicable Diseases Threat Report).

From 23 to 26 June 2025, the Africa Centres for Disease Control and Prevention (Africa CDC), the Eswatini Ministry of Health, and the European Centre for Disease Control and Prevention (ECDC) co-organised a national One Health strategy workshop in the Kingdom of Eswatini.

Regional workshops were held in Abidjan, Côte d’Ivoire (24−26 June 2025) and Yaoundé, Cameroon (8−10 July 2025), focusing on the prioritisation of epidemic-prone diseases for emergency preparedness and response in Western and Central Africa.

From 10 to 12 September 2025, ECDC welcomed a delegation from the ASEAN Centre for Public Health Emergencies and Emerging Diseases (ACPHEED) for a benchmarking visit.

The global cholera statistics for 2024, shows an increase in both the number of people who fell sick and died from the disease. Reported cholera cases rose by 5% and deaths by 50% in 2024 compared to 2023, with more than 6000 people dying from a disease that is both preventable and treatable.

Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya virus disease in its weekly threat report (Communicable Diseases Threat Report).

From 7 to 12 September 2025, the European Centre for Disease Prevention and Control (ECDC) and the European Health Task Force (EUHTF), in collaboration with the GOARN Operational Support Team, hosted the GOARN Outbreak Response Scenario Training in Stockholm, Sweden.

The latest survey from ECDC, the fourth of its kind, confirms that Candidozyma auris (formerly Candida auris) continues to spread quickly across European hospitals.

From 25–29 August , 48 fellows from European epidemiological training programmes and 34 facilitators gathered at the Instituto Nacional de Saúde Doutor Ricardo Jorge (INSA) in Lisbon, Portugal to strengthen their scientific communication skills as part of the 2025 Project Review Module.